Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?

被引：0
|
作者：
Goupille, Philippe [1 ]
Wendling, Daniel [2 ]
机构：
[1] Univ Tours, Trousseau Hosp, Rheumatol Dept, CHU Tours,EA 6295, Ave Republ, F-37044 Tours 9, France
[2] Univ Franche Comte, Rheumatol Dept, CHU Besancon, EA 4266, Besancon, France
来源：
JOINT BONE SPINE | 2024年 / 91卷 / 03期
关键词：
Axial spondyloarthritis; Treatment; C-reactive protein; CLINICAL-RESPONSE; DOUBLE-BLIND; ADALIMUMAB; PREDICTORS; EFFICACY; THERAPY; SAFETY;
D O I：
10.1016/j.jbspin.2023.105662
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 29 条
  • [1] Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
    Atzeni, Fabiola
    Carriero, Antonio
    Boccassini, Laura
    D'Angelo, Salvatore
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 141 - 153
  • [2] Drug Survival in Spondyloarthritis: Anti-IL17 Outperforms Anti-TNF in First Biologic Treatment
    Pham, Thao
    Curmin, Raphaelle
    Flachaire, Benoit
    Tubach, Florence
    Miceli, Corinne
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4732 - 4733
  • [3] Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis
    Olivieri, I.
    D'Angelo, S.
    Palazzi, C.
    Leccese, P.
    Nigro, A.
    Padula, A.
    REUMATISMO, 2013, 65 (01) : 1 - 3
  • [4] Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions
    Frieder, Jillian
    Kivelevitch, Dario
    Haugh, Isabel
    Watson, Ian
    Menter, Alan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 88 - 101
  • [5] Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
    Zuzana Jiraskova Zakostelska
    Zuzana Reiss
    Helena Tlaskalova-Hogenova
    Filip Rob
    Dermatology and Therapy, 2023, 13 : 911 - 933
  • [6] SERUM OSTEOPROTEGERIN IS DECREASED BY ANTI-TNF TREATMENT AND CORRELATES TO C-REACTIVE PROTEIN LEVELS
    Pastorelli, L.
    Galliera, E.
    Dogliotti, G.
    De Salvo, C.
    Tosetti, G.
    Banfi, G.
    Corsi, M. M.
    Vecchi, M.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S226 - S226
  • [7] Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents
    Sener, Seher
    Basaran, Ozge
    Akca, Ummusen Kaya
    Atalay, Erdal
    Cuceoglu, Muserref Kasap
    Balik, Zeynep
    Aliyev, Emil
    Bayindir, Yagmur
    Batu, Ezgi Deniz
    Hazirolan, Tuncay
    Bilginer, Yelda
    Ozen, Seza
    RHEUMATOLOGY, 2022, 61 (12) : 4885 - 4891
  • [8] Anti-TNFα Treatment Increases IL-17A+and IL-22+T Cells in Spondyloarthritis Regardless of Concomittant Gut Inflammation
    Andersen, Thomas
    Ostgard, Rene
    Deleuran, Bent
    Hvid, Malene
    Glerup, Henning
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S765 - S765
  • [9] Ixekizumab Is Effective in the Treatment of Radiographic Axial Spondyloarthritis Regardless of the Level of C-Reactive Protein or Magnetic Resonance Imaging Scores
    Maksymowych, Walter
    Gallo, Gaia
    Bolce, Rebecca
    Zhao, Fangyi
    Geneus, Vladimir
    Ostergaard, Mikkel
    Tada, Kurisu
    Deodhar, Atul
    Gensler, Lianne
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1050 - 1050
  • [10] Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials
    Damien Roche
    Martin Badard
    Laurent Boyer
    Pierre Lafforgue
    Thao Pham
    Arthritis Research & Therapy, 23
123